Lacombe, C.; De Rycke, O.; Couvelard, A.; Turpin, A.; Cazes, A.; Hentic, O.; Gounant, V.; Zalcman, G.; Ruszniewski, P.; Cros, J.;
et al. Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms. Cancers 2021, 13, 643.
https://doi.org/10.3390/cancers13040643
AMA Style
Lacombe C, De Rycke O, Couvelard A, Turpin A, Cazes A, Hentic O, Gounant V, Zalcman G, Ruszniewski P, Cros J,
et al. Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms. Cancers. 2021; 13(4):643.
https://doi.org/10.3390/cancers13040643
Chicago/Turabian Style
Lacombe, Caroline, Ophélie De Rycke, Anne Couvelard, Anthony Turpin, Aurélie Cazes, Olivia Hentic, Valérie Gounant, Gérard Zalcman, Philippe Ruszniewski, Jérôme Cros,
and et al. 2021. "Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms" Cancers 13, no. 4: 643.
https://doi.org/10.3390/cancers13040643
APA Style
Lacombe, C., De Rycke, O., Couvelard, A., Turpin, A., Cazes, A., Hentic, O., Gounant, V., Zalcman, G., Ruszniewski, P., Cros, J., & de Mestier, L.
(2021). Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms. Cancers, 13(4), 643.
https://doi.org/10.3390/cancers13040643